Madrigal Pharmaceuticals Inc
Company Profile
Business description
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
Contact
200 Barr Harbor Drive
Suite 200, Four Tower Bridge
West Conshohocken PA 19428
USAT: +1 267 824-2827
E: IR@madrigalpharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
376
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,323.50 | 30.40 | 0.37% |
CAC 40 | 7,459.34 | 24.27 | 0.33% |
DAX 40 | 18,609.05 | 90.66 | 0.49% |
Dow JONES (US) | 41,096.77 | 235.06 | 0.58% |
FTSE 100 | 8,237.74 | 3.23 | -0.04% |
HKSE | 17,369.09 | 128.70 | 0.75% |
NASDAQ | 17,569.68 | 174.14 | 1.00% |
Nikkei 225 | 36,581.76 | 251.51 | -0.68% |
NZX 50 Index | 12,832.55 | 12.27 | 0.10% |
S&P 500 | 5,595.76 | 41.63 | 0.75% |
S&P/ASX 200 | 8,099.90 | 24.20 | 0.30% |
SSE Composite Index | 2,704.09 | 13.03 | -0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Red 5 Ltd RED | 0.33 | 0.03 | 8.20% |
Latin Resources Ltd LRS | 0.20 | 0.01 | 2.56% |
Pilbara Minerals Ltd PLS | 2.90 | 0.02 | 0.69% |
Bowen Coking Coal Ltd BCB | 0.01 | 0.00 | 0.00% |
Telstra Group Ltd TLS | 3.96 | 0.00 | 0.00% |
Appen Ltd APX | 1.55 | 0.05 | 3.33% |
Imugene Ltd IMU | 0.05 | 0.00 | 0.00% |
South32 Ltd S32 | 3.19 | 0.11 | 3.57% |
Fortescue Ltd FMG | 17.50 | 0.84 | 5.04% |
Resolute Mining Ltd RSG | 0.74 | 0.04 | 5.76% |